Literature DB >> 33981074

A network analysis of COVID-19 mRNA vaccine patents.

Mario Gaviria1, Burcu Kilic2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33981074     DOI: 10.1038/s41587-021-00912-9

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  13 in total

1.  Unseating big pharma: the radical plan for vaccine equity.

Authors:  Amy Maxmen
Journal:  Nature       Date:  2022-07       Impact factor: 69.504

2.  Saving millions of lives but some resources squandered: emerging lessons from health research system pandemic achievements and challenges.

Authors:  Stephen R Hanney; Sharon E Straus; Bev J Holmes
Journal:  Health Res Policy Syst       Date:  2022-09-10

3.  University Technology Transfer Has Failed to Improve Access to Global Health Products during the COVID-19 Pandemic.

Authors:  Matthew Herder; E Richard Gold; Srinivas Murthy
Journal:  Healthc Policy       Date:  2022-05

4.  The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells.

Authors:  Yelee Kim; Hyosuk Kim; Eun Hye Kim; Hochung Jang; Yeongji Jang; Sung-Gil Chi; Yoosoo Yang; Sun Hwa Kim
Journal:  Pharmaceutics       Date:  2022-06-15       Impact factor: 6.525

5.  The Emergence of Genome Editing-Innovation Network Dynamics of Academic Publications, Patents, and Business Activities.

Authors:  Natalie Laibach; Stefanie Bröring
Journal:  Front Bioeng Biotechnol       Date:  2022-04-14

6.  Understanding vaccination in the era of pandemic.

Authors:  Mohammad Yusuf Hasan; Rizwan Ahmad
Journal:  Int J Health Sci (Qassim)       Date:  2021 Nov-Dec

7.  Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem.

Authors:  Julia Barnes-Weise; Ana Santos Rutschman; Reid Adler
Journal:  J Epidemiol Community Health       Date:  2022-02-09       Impact factor: 3.710

Review 8.  Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases.

Authors:  Nusrat Zahan Rouf; Sumit Biswas; Nawseen Tarannum; Labiba Mustabina Oishee; Mutia Masuka Muna
Journal:  RNA Biol       Date:  2021-12-31       Impact factor: 4.652

Review 9.  TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines.

Authors:  Shiri Mermelstein; Hilde Stevens
Journal:  Pharmaceutics       Date:  2021-12-27       Impact factor: 6.525

10.  The Nanoparticle-Enabled Success of COVID-19 mRNA Vaccines and the Promise of Microneedle Platforms for Pandemic Vaccine Response.

Authors:  Senta M Kapnick
Journal:  DNA Cell Biol       Date:  2021-12-24       Impact factor: 3.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.